Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123088) titled 'Prognostic Comparison of 100 vs. 150 mCi 131I Adjuvant Therapy in Patients with Intermediate-to-High Risk Differentiated Thyroid Cancer: A Multicenter Retrospective Cohort Study' on April 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai Tenth People's Hospital
Condition:
Patients with intermediate-to-high risk differentiated thyroid cancer who have undergone total/near-total thyroidectomy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: The moderate-dose adjuvant therapy group and the high-dose adjuvant therapy...